Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Stifel analysts maintained a Buy rating on Zscaler stock (NASDAQ:ZS) with a price target of $235.00, above the current trading price of $206.50. The cybersecurity company, currently valued at $31.8 ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Dayforce Inc (NYSE:DAY – Free Report) by 31.8% during the 4th quarter, Holdings Channel reports. The firm owned 19,028 shares ...

Tesla (NASDAQ:TSLA – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $492.00 to ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

We recently compiled a list of the 10 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.37%, which ...

Today’s Forbes Daily covers El Segundo’s defense tech movement, Trump’s funding violation, Eric Adams update, Elon Musk’s bid to buy OpenAI, Super Bowl ratings and more.

"Opinions on Elon Musk have taken a turn for the worse along political affiliations," Stifel analyst Stephen Gengaro said.